Toshito Nakagawa Selected Research

Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)

1/2018

Development of a Novel Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist (CH5447240), a Potent and Orally Available Small Molecule for Treatment of Hypoparathyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshito Nakagawa Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 05/2010
3	Neoplasms (Cancer) 07/2017 - 12/2010
2	Gout 01/2021 - 04/2016
1	Hypoparathyroidism 01/2018
1	Hyperuricemia 04/2016
1	Body Weight (Weight, Body) 07/2009
1	Obesity 07/2009

Drug/Important Bio-Agent (IBA)

4	Androgen Receptors (Androgen Receptor)IBA 04/2015 - 05/2010
3	6- (3- (4- cyano- 3- trifluoromethylphenyl)- 5,5- dimethyl- 4- oxo- 2- thioxoimidazolidin- 1- yl)pyridine- 2- sulfonic acid amideIBA 04/2015 - 12/2010
2	UR-1102IBA 01/2021 - 04/2016
2	Hormones (Hormone)IBA 04/2015 - 05/2010
1	Cytochrome P-450 CYP2C9IBA 01/2021
1	Uricosuric AgentsIBA 01/2021
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 01/2018
1	CH5447240IBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 07/2017
1	alectinibIBA 07/2017
1	Uric Acid (Urate)IBA 04/2016
1	bicalutamide (Casodex)FDA LinkGeneric 04/2015
1	Biological ProductsIBA 09/2011
1	AcidsIBA 07/2009
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2009
1	AmidesIBA 07/2009
1	Therapeutic UsesIBA 07/2009

Therapy/Procedure

3	Castration 04/2015 - 12/2010
1	Therapeutics 04/2016